These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24890812)

  • 61. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.
    Manca G; Romanini A; Rubello D; Mazzarri S; Boni G; Chiacchio S; Tredici M; Duce V; Tardelli E; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):105-13. PubMed ID: 24835287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [For the benefit of the patient: the sentinel node excision].
    Satzger I; Klein M; Löser C; Möhrle M; Reske S; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):922-6. PubMed ID: 22026360
    [No Abstract]   [Full Text] [Related]  

  • 63. Screening for conjunctival melanoma metastasis: literature review.
    Missotten GS; de Wolff-Rouendaal D; de Keizer RJ
    Bull Soc Belge Ophtalmol; 2007; (306):23-30. PubMed ID: 18251451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Advances in sentinel lymph node mapping for patients with melanoma.
    Brady MS
    Future Oncol; 2012 Feb; 8(2):191-203. PubMed ID: 22335583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy.
    McCormack CJ; Conyers RK; Scolyer RA; Kirkwood J; Speakman D; Wong N; Kelly JW; Henderson MA
    Melanoma Res; 2014 Oct; 24(5):437-47. PubMed ID: 24892957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathologic examination of the sentinel lymph node in melanoma.
    Goscin C; Glass LF; Messina JL
    Surg Oncol Clin N Am; 1999 Jul; 8(3):427-34, viii. PubMed ID: 10448687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Angiogenesis and lymphangiogenesis of skin cancers.
    Dadras SS; Detmar M
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Important first chance.
    Avery JK
    J Ark Med Soc; 2007 May; 103(11):269. PubMed ID: 17539456
    [No Abstract]   [Full Text] [Related]  

  • 69. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Failure to identify the sentinel lymph node for cutaneous melanoma--significant prognostic and management implications.
    Moncrieff M; Herbert J; Hancock K; Green AR
    Br J Plast Surg; 2005 Jul; 58(5):753-5. PubMed ID: 15992535
    [No Abstract]   [Full Text] [Related]  

  • 71. [Lymph node sonography in the after care of malignant melanoma].
    Stutte H; Erbe S; Rassner G
    Hautarzt; 1989 Jun; 40(6):344-9. PubMed ID: 2666344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.
    Bichakjian CK; Halpern AC; Johnson TM; Foote Hood A; Grichnik JM; Swetter SM; Tsao H; Barbosa VH; Chuang TY; Duvic M; Ho VC; Sober AJ; Beutner KR; Bhushan R; Smith Begolka W;
    J Am Acad Dermatol; 2011 Nov; 65(5):1032-47. PubMed ID: 21868127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
    J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Therapeutic manual of malignant melanoma].
    Moroi Y
    Fukuoka Igaku Zasshi; 2009 Feb; 100(2):51-8. PubMed ID: 19455975
    [No Abstract]   [Full Text] [Related]  

  • 75. Investigative studies in the diagnosis and treatment of melanoma.
    Seigler HF
    Invest Radiol; 1986 Jul; 21(7):596-600. PubMed ID: 3733389
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current guidelines in melanoma treatment. Melanoma Working Group of Gent and Bordet.
    Brochez L; Verhaeghe E; Sales F; Del Marmol V; Deraemaecker R; Vossaert K; Naeyaert JM
    Dermatology; 2000; 200(2):160-6. PubMed ID: 10773711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thickness of malignant melanoma: global analysis of related factors.
    Kopf AW; Welkovich B; Frankel RE; Stoppelmann EJ; Bart RS; Rogers GS; Rigel DS; Friedman RJ; Levenstein MJ; Gumport SL
    J Dermatol Surg Oncol; 1987 Apr; 13(4):345-90, 401-20. PubMed ID: 3558930
    [No Abstract]   [Full Text] [Related]  

  • 78. Revised UK guidelines for the management of cutaneous melanoma 2010.
    Marsden JR; Newton-Bishop JA; Burrows L; Cook M; Corrie PG; Cox NH; Gore ME; Lorigan P; Mackie R; Nathan P; Peach H; Powell B; Walker C;
    J Plast Reconstr Aesthet Surg; 2010 Sep; 63(9):1401-19. PubMed ID: 20728418
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management of stage I malignant melanoma.
    Griego RD; Zitelli JA
    Dermatol Surg; 1996 Aug; 22(8):730-3. PubMed ID: 8780767
    [No Abstract]   [Full Text] [Related]  

  • 80. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dummer R; Hauschild A; Guggenheim M; Keilholz U; Pentheroudakis G;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii86-91. PubMed ID: 22997461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.